Report cover image

Oncology Therapy Market - 2024-2033

Publisher DataM Intelligence 4Market Research LLP
Published Jun 19, 2025
Length 219 Pages
SKU # DTAM21130463

Description

Oncology Therapy Market Overview:
The Oncology Therapy Market was valued at US$ 193.98 billion in 2024 and is anticipated to reach US$ 440.26 billion by 2033, at a CAGR of 0.096 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Oncology Therapy Market.

This report delivers a comprehensive overview of the Oncology Therapy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oncology Therapy Market. The Oncology Therapy Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Oncology Therapy Market Scope:
Key Players
• Amgen Inc.

Major Highlights
This report delivers a comprehensive overview of the Oncology Therapy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oncology Therapy Market. The Oncology Therapy Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

219 Pages
1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
3. Market Highlights and Strategic Takeaways
3.1. Key Trends and Future Projections
4. Snippet by Therapy
4.1. Snippet by Application
4.2. Snippet by End-User
4.3. Snippet by Region
5. Dynamics
5.1. Impacting Factors
5.1.1. Drivers
5.1.1.1. Rising Prevalence of Cancer
5.1.1.2. Rising Adoption of Combination Therapies
5.1.1.3. XX
5.1.2. Restraints
5.1.2.1. Adverse Effects Associated with Various Oncology Therapies
5.1.2.2. High Cost of Treatment for Oncology Therapy
5.1.2.3. XX
5.1.3. Opportunity
5.1.3.1. Personalized and Precision Oncology
5.1.3.2. XX
5.1.4. Impact Analysis
6. Strategic Insights and Industry Outlook
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established Leaders with the Largest Marketing Brand
6.1.3. Market Leaders with Established Products
6.2. Latest Developments and Breakthroughs
6.3. Regulatory and Reimbursement Landscape
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. South America
6.3.5. Middle East & Africa
6.4. Porter’s Five Forces Analysis
6.5. Patent Analysis
6.6. SWOT Analysis
6.7. Unmet Needs and Gaps
6.8. Recommended Strategies for Market Entry and Expansion
6.9. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.10. Pricing Analysis and Price Dynamics
7. Oncology Therapy Market, By Therapy
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy
7.1.2. Market Attractiveness Index, By Therapy
7.2. Chemotherapy*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Alkylating Agents
7.2.4. Antimetabolites
7.2.5. Anti-tumor Antibiotics
7.2.6. Topoisomerase Inhibitors
7.2.7. Others
7.3. Targeted Therapy
7.3.1. Monoclonal Antibodies
7.3.2. Small Molecule Inhibitors
7.4. Immunotherapy
7.4.1. Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)
7.4.2. CAR-T Cell Therapy
7.4.3. Cancer Vaccines
7.4.4. Cytokines
7.4.5. Others
7.5. Hormonal Therapy
7.5.1. Anti-estrogens
7.5.2. Aromatase Inhibitors
7.5.3. Luteinizing Hormone-Releasing Hormone (LHRH) Agonists/Antagonists
7.5.4. Others
7.6. Radiation Therapy
7.7. Others
8. Oncology Therapy Market, By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Breast Cancer*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Lung Cancer
8.4. Blood Cancer
8.5. Prostate Cancer
8.6. Colorectal Cancer
8.7. Stomach Cancer
8.8. Liver Cancer
8.9. Esophageal Cancer
8.10. Cervical Cancer
8.11. Ovarian Cancer
8.12. Bladder Cancer
8.13. Head and Neck Cancer
8.14. Skin Cancer (Melanoma)
8.15. Pancreatic Cancer
8.16. Kidney Cancer
8.17. Others
9. Oncology Therapy Market, By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cancer Research Centers
9.4. Specialty Clinics
9.5. Others
10. Oncology Therapy Market, By Regional Market Analysis and Growth Opportunities
11. Introduction
11.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.1. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.6.1. U.S.
11.2.6.2. Canada
11.2.6.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.6.1. Germany
11.3.6.2. UK
11.3.6.3. France
11.3.6.4. Spain
11.3.6.5. Italy
11.3.6.6. Rest of Europe
11.4. Asia-Pacific
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.6.1. China
11.4.6.2. India
11.4.6.3. Japan
11.4.6.4. South Korea
11.4.6.5. Rest of Asia-Pacific
11.5. South America
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.6.1. Brazil
11.5.6.2. Argentina
11.5.6.3. Rest of South America
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape and Market Positioning
13. Competitive Overview and Key Market Players
13.1. Market Share Analysis and Positioning Matrix
13.2. Strategic Partnerships, Mergers & Acquisitions
13.3. Key Developments in Product Portfolios and Innovations
13.4. Company Benchmarking
14. Company Profiles
14.1. Amgen Inc.*
14.1.1. Company Overview
14.1.2. Product Portfolio
14.1.2.1. Product Description
14.1.2.2. Product Key Performance Indicators (KPIs)
14.1.2.3. Historic and Forecasted Product Sales
14.1.2.4. Product Sales Volume
14.2. Financial Overview
14.2.1. Company Revenue
14.2.1.1. Geographical Revenue Shares
14.2.1.1.1. Revenue Forecasts
14.2.1.2. Key Developments
14.2.1.2.1. Mergers & Acquisitions
14.2.1.2.2. Key Product Development Activities
14.2.1.2.3. Regulatory Approvals, etc.
14.2.1.3. SWOT Analysis
14.2.2. AstraZeneca
14.2.3. Bayer AG
14.2.4. Merck & Co., Inc.
14.2.5. Johnson & Johnson Services, Inc.
14.2.6. F. Hoffmann-La Roche Ltd
14.2.7. Novartis AG
14.2.8. GSK plc
14.2.9. Eli Lilly and Company
14.2.10. Rigel Pharmaceuticals, Inc. (*LIST NOT EXHAUSTIVE)
15. Assumptions and Research Methodology
15.1. Data Collection Methods
15.2. Data Triangulation
15.3. Forecasting Techniques
15.4. Data Verification and Validation
16. Appendix
16.1. About Us and Services
16.2. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us